Positron Emission Tomography Devices Market Research Report – Global Forecast till 2023

Positron Emission Tomography Devices (PET) Market Research Report: By Product Type (Full Ring and Partial Ring PET Scanners), Applications (Cardiology, Oncology, Neurology, and Others), End User (Hospitals, and Others) – Global Forecast Till 2023

ID: MRFR/HC/5787-HCR | February 2021 | Region: Global | 90 pages

Market Scenario


Global positron emission tomography devices (PET) market is expected to grow significantly over the forecast period. It is projected to grow at a CAGR of 5.6% over the forecast period.


Positron emission tomography is an imaging test that examines the chemical activity in parts of the body. In this test, tracer is injected, swallowed or inhaled, depending on which organ or tissue is being studied. The tracer accumulates in diseased areas of the body that have higher levels of chemical activity. On a PET scan, these areas show up as bright spots.


Rising adoption of PET scanning is one of the key factors driving the positron emission tomography devices (PET) market. On November, 2018, Bioasis Technologies announced positive results from peripheral whole-body PET/CT scan study in non-human primates with lead investigational candidate xB3-001.


Various other factors such as increasing cases of cancer, technological advancements, favourable reimbursement, presence of a large target patient population and rising patient awareness regarding the benefits of positron emission tomography scanning are also expected to propel the growth of the market.


However, stringent regulatory guidelines, cost associated with PET scan, and shorter half-life of radioisotopes can hamper the market growth over the forecast period.


Segmentation


The global positron emission tomography devices (PET) market is segmented based on product type, applications, end user and region.


The global market for positron emission tomography devices (PET), by product type is segmented into full ring PET scanners and partial ring PET scanners.


The market, by applications, is segmented into cardiology, neurology, oncology, orthopaedics, urology, gastroenterology, and others


Based on end user, positron emission tomography devices (PET) market is segmented into hospitals, clinics, diagnostic centres, and others. The hospitals segment is anticipated to hold the largest market share owing to the increasing cases of cancer. The diagnostic centres are expected to grow at the highest CAGR owing to the rising demand for early diagnosis.


In the current scope of the study, the above-mentioned segments are covered into the four global regions, namely the Americas, Europe, Asia-Pacific and the Middle East & African region.


The positron emission tomography devices (PET) market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.


The European positron emission tomography devices (PET) market has been segmented into Western Europe and Eastern Europe. Western Europe has been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.  The positron emission tomography devices (PET) market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The positron emission tomography devices (PET) market in the Middle East & Africa has been segmented into the Middle East and Africa.


Regional Market Summary


Global Positron Emission Tomography Devices (PET) market Share (%), by Region, 2017


Positron Emission Tomography Devices (PET) market


Sources: MRFR Analysis


The Americas dominated the global market for positron emission tomography devices (PET) owing to presence of major market players and increased prevalence of Alzheimer's dementia within the region. As per the data suggested by the Alzheimer's Association, an estimated 5.7 million Americans of all ages are living with Alzheimer's dementia in 2018.


Europe is expected to hold the second largest position in the global positron emission tomography devices (PET) market. The market growth in this region is attributed to the government support and improving healthcare related research & development activities.


Asia Pacific was projected to be the fastest growing region in 2017. Factors such as, growing cases of head and neck cancer, and increasing healthcare expenditure drives the regional markets of the Asia Pacific region. According to the 2018 data suggested by the Australian Institute of Health and Welfare, around 5,091 new cases of head and neck cancer were diagnosed and around 1,034 number of deaths occurred from head and neck cancer in Australia.


On the other hand, the Middle East and Africa held least share in the global positron emission tomography devices (PET) market due to the low per capita income, especially within the African region.


Key players


Some of the key players in the global positron emission tomography devices (PET) market are Agfa Healthcare, Gamma Medica Inc., GE Healthcare, Neusoft Medical Systems, Oncovision, Koninklijke Philips N.V., Positron Corporation, Siemens AG, Segami Corporation, Spectrum Dynamics Ltd., Naviscan, Inc. MedX Holdings Inc., Modus Medical Devices Inc., Radiology Oncology Systems, Inc., Yangzhou Kindsway Biotech Co. Ltd., Toshiba Corporation, Hitachi, Ltd., and others.


Research Methodology


Market Research Future research is conducted by industry experts who offer insights into industry structure, market segmentation, assessment, Competitive Landscape (CL), penetration, as well as on emerging trends. Besides primary interviews (~ 80%) and secondary research (~ 20%), their analysis is based on their years of professional expertise in respective industries. Our analysts also predict where the market will be headed in the next five to ten years, by analysing historical trends and current market positions. Furthermore, the varying trends of segments and categories geographically presented are studied and are estimated based on the primary and secondary research.



  • Primary Research


Extensive primary research was conducted to gain a deeper insight of the market and the industry performance. In this particular report we have conducted primary surveys (interviews) with key level executives (VPs, CEOs, Marketing Directors, Business Development Managers, and many more) of major players who are active in the market. In addition to analyzing the current and historical trends, our analysts predict where the market is headed, over the next five to ten years.



  • Secondary Research


Secondary research was mainly used to collect and identify information useful for extensive, technical, market-oriented, and commercial study of the Positron Emission Tomography Devices (PET). It was also used to obtain key information about major players, market classification, and segmentation according to industry trends, geographical markets, and developments related to the market and perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, SEC filings, journals, white papers, corporate presentations, company web sites, international organization of chemical manufacturers, some paid databases, and many others.


Intended Audience



  • Medical Device Companies

  • Government and Private Laboratories

  • Research and Development (R&D) companies

  • Medical Research Laboratories

  • Market Research and Consulting Service Providers


Market Segmentation and Key Market Players


Global Positron Emission Tomography Devices (PET) Market, by Product Type



  • Full Ring PET Scanners

  • Partial Ring PET Scanners


Global Positron Emission Tomography Devices (PET) Market, by Applications



  • Cardiology

  • Neurology

  • Oncology

  • Orthopedics

  • Urology

  • Gastroenterology

  • Othe

  • Others


Global Positron Emission Tomography Devices (PET) Market, by End User



  • Hospitals

  • Clinics

  • Diagnostic Centers 

  • Others



Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Macroeconomic Indicators

4.5 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

Chapter 6. Global Positron Emission Tomography Devices (PET) Market, by Product Type

6.1 Introduction

6.2 Full Ring PET Scanners

Market Estimates &Forecast, by Region, 2018–2023

Market Estimates &Forecast, by Country, 2018–2023

6.3 Partial Ring PET Scanners

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

Chapter 7. Global Positron Emission Tomography Devices (PET) Market, by Applications

7.1 Introduction

7.2 Cardiology

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

7.3 Neurology

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

7.4 Oncology

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

7.5 Orthopedics

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

7.6 Urology

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

7.7 Gastroenterology

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

7.7 Others

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

Chapter 8. Global Positron Emission Tomography Devices (PET) Market, by End User

8.1 Introduction

8.2 Hospitals

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

8.3 Clinics

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

8.4 Diagnostic Centers

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

8.5 Others

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

Chapter 9. Global Positron Emission Tomography Devices (PET) Market, by Region

9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 U.S.

9.2.1.2 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 UK

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia-Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 South Korea

9.4.6 Rest of Asia-Pacific

9.5 Middle East & Africa

9.5.1 Middle East

9.5.2 Africa

Chapter 10. Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

Chapter 11. Company Profiles

11.1 Agfa Healthcare

11.1.1 Company Overview

11.1.2 Type Overview

11.1.3 Financials Overview

11.1.4 Key Developments

11.1.5 SWOT Analysis

11.2 Gamma Medica Inc.

11.2.1 Company Overview

11.2.2 Type Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 GE Healthcare

11.3.1 Company Overview

11.3.2 Type Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 Neusoft Medical Systems

11.4.1 Company Overview

11.4.2 Technologys/Business Segment Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 Koninklijke Philips N.V.

11.5.1 Company Overview

11.5.2 Type Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.5.5 SWOT Analysis

11.6 Positron Corporation

11.6.1 Company Overview

11.6.2 Type Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.6.5 SWOT Analysis

11.7 Siemens AG

11.7.1 Overview

11.7.2 Type Overview

11.7.3 Financial Overview

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 Segami Corporation

11.8.1 Overview

11.8.2 Type/ Technology Overview

11.8.3 Financials

11.8.4 Key Developments

11.8.5 SWOT Analysis

11.9 Oncovision

11.9.1 Overview

11.9.2 TypeOverview

11.9.3 Financials

11.9.4 Key Developments

11.9.5 SWOT Analysis

11.10 Naviscan, Inc.

11.10.1 Overview

11.10.2 TypeOverview

11.10.3 Financials

11.10.4 Key Developments

11.10.5 SWOT Analysis

11.11 MedX Holdings Inc.

11.11.1 Overview

11.11.2 TypeOverview

11.11.3 Financials

11.11.4 Key Developments

11.11.5 SWOT Analysis

11.12 Modus Medical Devices Inc.

11.12.1 Overview

11.12.2 Type Overview

11.12.3 Financials

11.12.4 Key Developments

11.12.5 SWOT Analysis

11.13 Radiology Oncology Systems, Inc.

11.13.1 Overview

11.13.2 Type Overview

11.13.3 Financials

11.13.4 Key Developments

11.13.5 SWOT Analysis

11.14 Yangzhou Kindsway Biotech Co. Ltd.

11.14.1 Overview

11.14.2 Type Overview

11.14.3 Financials

11.14.4 Key Developments

11.14.5 SWOT Analysis

11.15 Toshiba Corporation

11.15.1 Overview

11.15.2 Type Overview

11.15.3 Financials

11.15.4 Key Developments

11.15.5 SWOT Analysis

11.16 Other

Chapter 12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s Viewpoint

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Predictionsfor the global positron emission tomography devices (PET) market

Chapter 13. Appendix

LIST OF TABLES

Table 1 Global Positron Emission Tomography Devices (PET) Market Synopsis, 2018–2023

Table 2 Global Positron Emission Tomography Devices (PET) Market Estimates and Forecast, 2018–2023 (USD Million)

Table 3 Global Positron Emission Tomography Devices (PET) Market, by Region, 2018–2023 (USD Million)

Table 4 Global Positron Emission Tomography Devices (PET) Market, by Product Type, 2018–2023 (USD Million)

Table 5 Global Positron Emission Tomography Devices (PET) Market, by Applications, 2018–2023 (USD Million)

Table 6 Global Positron Emission Tomography Devices (PET) Market, End User, 2018–2023 (USD Million)

Table 7 North America: Positron Emission Tomography Devices (PET) Market, by Product Type, 2018–2023 (USD Million)

Table 8 North America: Positron Emission Tomography Devices (PET) Market, by Applications, 2018–2023(USD Million)

Table 9 North America: Positron Emission Tomography Devices (PET) Market, End User, 2018–2023 (USDMillion)

Table 10 US: Positron Emission Tomography Devices (PET) Market, by Product Type, 2018–2023 (USD Million)

Table 11 US: Positron Emission Tomography Devices (PET) Market, by Applications, 2018–2023 (USD Million)

Table 12 US: Positron Emission Tomography Devices (PET) Market, End User, 2018–2023 (USD Million)

Table 13 Canada:Positron Emission Tomography Devices (PET) Market,byProduct Type, 2018–2023 (USD Million)

Table 14 Canada: Positron Emission Tomography Devices (PET) Market, by Applications, 2018–2023 (USD Million)

Table 15 Canada: Positron Emission Tomography Devices (PET) Market, End User, 2018–2023 (USDMillion)

Table 16 South America: Positron Emission Tomography Devices (PET) Market, by Product Type, 2018–2023 (USD Million)

Table 17 South America: Positron Emission Tomography Devices (PET) Market, by Applications, 2018–2023 (USD Million)

Table 18 South America: Positron Emission Tomography Devices (PET) Market, End User, 2018–2023 (USDMillion)

Table 19 Europe: Positron Emission Tomography Devices (PET) Market, by Product Type, 2018–2023 (USD Million)

Table 20 Europe: Positron Emission Tomography Devices (PET) Market, by Applications, 2018–2023 (USD Million)

Table 21 Europe: Positron Emission Tomography Devices (PET) Market, End User, 2018–2023 (USD Million)

Table 22 Western Europe: Positron Emission Tomography Devices (PET) Market, by Product Type, 2018–2023 (USDMillion)

Table 23 Western Europe: Positron Emission Tomography Devices (PET) Market, by Applications, 2018–2023 (USD Million)

Table 24 Western Europe: Positron Emission Tomography Devices (PET) Market, by End User, 2018–2023(USD Million)

Table 25 Eastern Europe: Positron Emission Tomography Devices (PET) Market, by Product Type, 2018–2023 (USD Million)

Table 26 Eastern Europe: Positron Emission Tomography Devices (PET) Market, by Applications, 2018–2023 (USD Million)

Table 27 Eastern Europe: Positron Emission Tomography Devices (PET) Market, End User, 2018–2023(USD Million)

Table 28 Asia-Pacific: Positron Emission Tomography Devices (PET) Market, by Product Type, 2018–2023 (USD Million)

Table 29 Asia-Pacific: Positron Emission Tomography Devices (PET) Market,by Applications, 2018–2023 (USD Million)

Table 30 Asia-Pacific: Positron Emission Tomography Devices (PET) Market, End User, 2018–2023 (USD Million)

Table 31 Middle East & Africa: Positron Emission Tomography Devices (PET) Market, by Product Type, 2018–2023 (USD Million)

Table 32 Middle East & Africa: Positron Emission Tomography Devices (PET) Market, by Applications,2018–2023 (USD Million)

Table 33 Middle East & Africa: Positron Emission Tomography Devices (PET) Market, End User, 2018–2023(USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Positron Emission Tomography Devices (PET) Market

Figure 3 Market Dynamics for Global Positron Emission Tomography Devices (PET) Market

Figure 4 Positron Emission Tomography Devices (PET) Market Share, by Product Type,2017

Figure 5 Positron Emission Tomography Devices (PET) Market Share, by Applications,2017

Figure 6 Positron Emission Tomography Devices (PET) Market Share, End User, 2017

Figure 7 Positron Emission Tomography Devices (PET) Market Share, by Region, 2017

Figure 8 North America: Positron Emission Tomography Devices (PET) Market Share, by Country, 2017

Figure 9 Europe: Positron Emission Tomography Devices (PET) Market Share, by Country, 2017

Figure 10 Asia-Pacific: Positron Emission Tomography Devices (PET) Market Share, by Country, 2017

Figure 11 Middle East & Africa: Positron Emission Tomography Devices (PET) Market Share, by Region, 2017

Figure 12 Positron Emission Tomography Devices (PET) Market : Company Share Analysis, 2017 (%)

Figure 13 Agfa Healthcare: Key Financials

Figure 14 Agfa Healthcare: Segmental Revenue

Figure 15 Agfa Healthcare: Geographical Revenue

Figure 16 Gamma Medica Inc. : Key Financials

Figure 17 Gamma Medica Inc. : Segmental Revenue

Figure 18 Gamma Medica Inc. : Geographical Revenue

Figure 19 GE Healthcare:Key Financials

Figure 20 GE Healthcare: Segmental Revenue

Figure 21 GE Healthcare: Geographical Revenue

Figure 22 Neusoft Medical Systems: Key Financials

Figure 23 Neusoft Medical Systems: Segmental Revenue

Figure 24 Neusoft Medical Systems: Geographical Revenue

Figure 25 Koninklijke Philips N.V.:Key Financials

Figure 26 Koninklijke Philips N.V.: Segmental Revenue

Figure 27 Koninklijke Philips N.V.: Geographical Revenue

Figure 28 Positron Corporation: Key Financials

Figure 29 Positron Corporation: Segmental Revenue

Figure 30 Positron Corporation: Geographical Revenue

Figure 31 Siemens AG: Key Financials

Figure 32 Siemens AG: Segmental Revenue

Figure 33 Siemens AG: Geographical Revenue

Figure 34 Segami Corporation:Key Financials

Figure 35 Segami Corporation: Segmental Revenue

Figure 36 Segami Corporation: Geographical Revenue

Figure 37 Oncovision: Key Financials

Figure 38 Oncovision: Segmental Revenue

Figure 39 Oncovision: Geographical Revenue

Figure 40 Naviscan, Inc.: Key Financials

Figure 41 Naviscan, Inc.: Segmental Revenue

Figure 42 Naviscan, Inc.: Geographical Revenue

Figure 43 MedX Holdings Inc. : Key Financials

Figure 44 MedX Holdings Inc. :Segmental Revenue

Figure 45 MedX Holdings Inc. : Geographical Revenue

Figure 46 Modus Medical Devices Inc.: Key Financials

Figure 47 Modus Medical Devices Inc.: Segmental Revenue

Figure 48 Modus Medical Devices Inc.: Geographical Revenue

Figure 49 Radiology Oncology Systems, Inc.: Key Financials

Figure 50 Radiology Oncology Systems, Inc.: Segmental Revenue

Figure 51 Radiology Oncology Systems, Inc.: Geographical Revenue

Figure 49 Yangzhou Kindsway Biotech Co. Ltd.: Key Financials

Figure 50 Yangzhou Kindsway Biotech Co. Ltd.: Segmental Revenue

Figure 51 Yangzhou Kindsway Biotech Co. Ltd.: Geographical Revenue

Figure 49 Toshiba Corporation: Key Financials

Figure 50 Toshiba Corporation: Segmental Revenue

Figure 51 Toshiba Corporation: Geographical Revenue




This table of content is tentative and subject to change as the research progresses.

Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.